Orgenesis Inc. (ORGS) Balance Sheet

OTC Pink: ORGSAssets, liabilities, debt and equity over 10 years.

ORGS balance sheet, 2024

December 31, 2024 · U.S. dollars

$1.4M assets = $38.9M liabilities + −$37.5M equity

What it owns$1.4MCash & ST investments: $78,000 (5.8%)Receivables: $40,000 (3.0%)Other current: $643,000 (47.6%)PP&E: $578,000 (42.8%)Other non-current: $12,000 (0.9%)=How it is financed$38.9MCurrent liabilities: $26.9M (69.2%)Current liabilities$26.9M · 69%Long-term debt: $8.5M (21.8%)Long-term debt$8.5M · 22%Other LT liabilities: $3.5M (9.0%)Other LT liabilities $3.5M

Liabilities exceed assets: shareholders’ equity is negative (−$37.5M).

Both columns are drawn to the same scale: what ORGS owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ORGS financial health

Current ratio0.03
Tight · current assets cover current liabilities 0.03×
Equity / assets−2,775.8%
Thin equity · of assets funded by shareholders
Cash / debt0.9%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2024.

ORGS balance sheet trends, 2016–2024

Orgenesis Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$33.5M2016$1.4M2024−30.0%/yr
Total liabilities$22.9M2016$38.9M2024+6.1%/yr
Shareholders’ equity$10.6M2016−$37.5M2024—
Cash & short-term investments$891,0002016$78,0002024−23.7%/yr
Total debt$9.8M2016$8.5M2024−1.6%/yr
Net cash (debt)−$8.9M2016−$8.4M2024+$555,000
Working capital−$10.4M2016−$26.2M2024−$15.8M
Book value per share$1.242016−$7.252024—
Current ratio0.2920160.032024−0.26
Debt / equity0.9320160.742022−0.19
Shares outstanding8.5M20165.2M2024−5.4%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ORGS assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ORGS liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ORGS debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ORGS balance sheet

Orgenesis Inc. annual balance sheet
2024202320222021202020192018201820172016
Assets
Cash & short-term investments$78,000$837,000$5.3M$5.5M$44.9M$11.4M$16.1M$16.1M$3.5M$891,000
Cash & equivalents$78,000$837,000$5.3M$5.5M$44.9M$11.4M$16.1M$16.1M$3.5M$891,000
Short-term investments———$152,000——————
Receivables$40,000$2.6M$39.8M$19.7M$3.3M$2.0M$11.2M$11.2M$2.2M$2.1M
Inventory$0$34,000$120,000$118,000$185,000$2.0M$1.7M$1.7M$725,000$400,000
Other current assets$643,000$642,000$1.1M$501,000$1.7M$10.5M$1.3M$1.3M$841,000$779,000
Total current assets$761,000$4.1M$46.3M$25.8M$50.1M$26.0M$30.3M$30.3M$7.3M$4.2M
Property, plant & equipment (net)$578,000$1.8M$25.1M$11.3M$4.5M$34.0M$11.9M$11.9M$5.1M$4.6M
Goodwill & intangible assets$0$8.6M$17.9M$20.2M$21.8M$29.1M$31.9M$31.9M$25.7M$24.6M
Long-term investments$0$8,000$135,000$152,000$175,000$2.6M$0$0$1.3M$0
Other non-current assets$12,000$56,000$1.5M$2.4M$1.1M$707,000$1.4M$1.4M$417,000$75,000
Total assets$1.4M$14.6M$90.9M$59.8M$77.7M$92.5M$75.4M$75.4M$39.9M$33.5M
Liabilities
Accounts payable$10.4M$6.6M$4.4M$5.2M$8.6M$5.5M$3.8M$3.8M$3.9M$4.6M
Short-term debt—$3.6M$5.1M$6.4M$4.6M$1.2M$1.0M$1.0M$3.2M$5.5M
Deferred revenue—$2.2M$1.6M$1.3M$751,000$11.4M$7.0M$7.0M$5.3M$1.5M
Total current liabilities$26.9M$16.4M$15.9M$15.4M$16.3M$31.6M$17.1M$17.1M$16.9M$14.6M
Long-term debt$8.5M$19.0M$13.3M$4.9M$7.3M$14.1M$3.5M$2.7M$4.5M$4.3M
Lease obligations$1.6M$334,000$2.4M$1.1M$1.5M$10.2M————
Other long-term liabilities$3.5M$161,000$2.4M$991,000$1.4M$40.8M$26.1M$27.0M$4.3M$4.0M
Total liabilities$38.9M$35.5M$31.7M$21.2M$25.0M$86.4M$46.8M$46.8M$25.7M$22.9M
Shareholders' equity
Common stock & paid-in capital—$3,000$3,000$3,000$3,000$2,000$1,000$1,000$1,000$12,000
Retained earnings (deficit)−$224.8M−$176.6M−$121.3M−$106.4M−$88.3M−$89.4M−$62.4M−$62.4M−$44.1M−$29.8M
Accumulated other comprehensive income—$65,000−$270,000$207,000$748,000$213,000$425,000$425,000$1.4M−$1.2M
Minority interest−$32,000$0$31.7M$143,000—$601,000————
Total shareholders' equity−$37.5M−$21.0M$27.6M$38.5M$52.6M$5.5M$28.4M$28.6M$14.1M$10.6M
Key figures
Total debt$8.5M$22.6M$20.3M$11.8M$12.9M$24.8M$3.7M$3.7M$7.7M$9.8M
Net cash (debt)−$8.4M−$21.8M−$15.0M−$6.4M$32.0M−$13.4M$12.3M$12.3M−$4.2M−$8.9M
Working capital−$26.2M−$12.3M$30.4M$10.4M$33.8M−$5.6M$13.2M$13.2M−$9.6M−$10.4M
Tangible book value−$37.5M−$29.6M$9.7M$18.3M$30.8M−$23.7M−$3.5M−$3.2M−$11.6M−$14.1M
Book value per share−$7.25−$0.72$1.10$1.59$2.47$0.34$2.12$2.14$1.45$1.24
Shares outstanding5.2M29.0M25.1M24.3M21.3M15.9M13.4M13.4M9.7M8.5M
Current ratio0.030.252.911.683.080.821.771.770.430.29
Quick ratio0.000.212.841.642.960.431.591.590.340.21
Debt / equity——0.740.310.254.520.130.130.540.93
Equity / assets−2,775.8%−144.2%30.3%64.3%67.7%5.9%37.6%38.0%35.4%31.6%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed —); data from EODHD.

ORGS financial position

At the end of fiscal 2024 (December 31, 2024), Orgenesis had total assets of $1.4 million (down 90.7% from a year earlier), total liabilities of $38.9 million and shareholders' equity of -$37.5 million. It held $0.1 million in cash and short-term investments against $8.5 million of debt, net debt of $8.4 million. Its current ratio was 0.03.

Related: ORGS income statement, ORGS cash flow statement, ORGS key metrics. See the ORGS stock overview for the latest quote and news.

ORGS balance sheet FAQ

What are Orgenesis's total assets?

Orgenesis reported total assets of $1.4 million at the end of fiscal 2024 (December 31, 2024), compared with $14.6 million a year earlier.

How much debt does Orgenesis have?

Orgenesis had $8.5 million of total debt at the end of fiscal 2024, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.

How much cash does Orgenesis have?

Orgenesis held $0.1 million in cash and short-term investments at the end of fiscal 2024; with $8.5 million of debt that is net debt of $8.4 million.

What is Orgenesis's book value?

Orgenesis's shareholders' equity (book value) was -$37.5 million at the end of fiscal 2024, or −$7.25 per share.

What is Orgenesis's current ratio?

Orgenesis had current assets of $0.8 million and current liabilities of $26.9 million, a current ratio of 0.03 (current liabilities exceed current assets).

Biotechnology: balance sheet